| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962739 | Vaccine | 2016 | 5 Pages |
Abstract
Three doses of bivalent rLP2086 were generally well tolerated in laboratory personnel and elicited protective functional immune responses reflective of broad coverage against MnB disease.
Keywords
hSBABivalent rLP2086Neisseria meningitidis serogroup BfHBPLP2086MNBSerogroup BSAEGMTLLOQMeningococcal diseaseACIPadverse eventSerious adverse eventconfidence intervallower limit of quantitationGeometric mean titerNeisseria meningitidisVaccineFactor H binding proteinAdvisory Committee on Immunization Practices
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
David M. Reiner, Prakash Bhuyan, Joseph J. Eiden, John Ginis, Shannon Harris, Kathrin U. Jansen, Qin Jiang, Thomas R. Jones, Robert E. O'Neill, Laura J. York, John L. Perez,